Cargando…

Apelin Improves Prognostic Value of HFSS (Heart Failure Survival Score) and MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) Scales in Ambulatory Patients with End-Stage Heart Failure †

This prospective study aimed to determine the effect of adding apelin to the MAGGIC (Meta-Analysis Global Group In Chronic Heart Failure) and HFSS (Heart Failure Survival Score) scales for predicting one-year mortality in 240 ambulatory patients accepted for heart transplantation (HT) between 2015–2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szczurek, Wioletta, Gąsior, Mariusz, Skrzypek, Michał, Szyguła-Jurkiewicz, Bożena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408713/ https://www.ncbi.nlm.nih.gov/pubmed/32698411 http://dx.doi.org/10.3390/jcm9072300

Ejemplares similares

The Utility of Pentraxin and Modified Prognostic Scales in Predicting Outcomes of Patients with End-Stage Heart Failure
por: Szczurek-Wasilewicz, Wioletta, et al.
Publicado: (2022)

Factors Associated with Ineffectiveness of Sildenafil Treatment in Patients with End-Stage Heart Failure and Elevated Pulmonary Vascular Resistance
por: Szczurek, Wioletta, et al.
Publicado: (2020)

Prognostic scales in advanced heart failure
por: Szczurek, Wioletta, et al.
Publicado: (2018)

Obesity in patients with end-stage heart failure
por: Król, Bogumiła, et al.
Publicado: (2018)

Oxidative stress and inflammatory markers – the future of heart failure diagnostics?
por: Szczurek, Wioletta, et al.
Publicado: (2015)

The role of statins in chronic heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

Mechanical circulatory support in heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2016)

Clinical features, management and mortality in diabetic and non-diabetic patients with heart failure – observations from the COMMIT-HF registry
por: Siedlecki, Łukasz, et al.
Publicado: (2017)

Investigation of the Role of Oxidative Stress and Factors Associated with Cardiac Allograft Vasculopathy in Patients after Heart Transplantation
por: Szczurek, Wioletta, et al.
Publicado: (2020)

Oxidative Stress Markers and Modified Model for End-Stage Liver Disease Are Associated with Outcomes in Patients with Advanced Heart Failure Receiving Bridged Therapy with Continuous-Flow Left Ventricular Assist Devices
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2021)

Factors associated with cardiac allograft vasculopathy after heart transplantation
por: Szczurek-Wasilewicz, Wioletta, et al.
Publicado: (2022)

Prognostic significance of addition of electrocardiographic findings to the MAGGIC heart failure risk score
por: Dogan, O, et al.
Publicado: (2023)

The Model for End-Stage Liver Disease (MELD) can predict outcomes in ambulatory patients with advanced heart failure who have been referred for cardiac transplantation evaluation
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

The role of statins in patients after heart transplantation
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2015)

Performance of the MAGGIC heart failure risk score and its modification with the addition of discharge natriuretic peptides
por: Sawano, Mitsuaki, et al.
Publicado: (2018)

Validation of the MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) heart failure risk score and the effect of adding natriuretic peptide for predicting mortality after discharge in hospitalized patients with heart failure
por: Khanam, Sayma Sabrina, et al.
Publicado: (2018)

Risk factors of cardiac allograft vasculopathy
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2015)

Meta‐Analysis Global Group in Chronic (MAGGIC) Heart Failure Risk Score: Validation of a Simple Tool for the Prediction of Morbidity and Mortality in Heart Failure With Preserved Ejection Fraction
por: Rich, Jonathan D., et al.
Publicado: (2018)

Comparison of MAGGIC and MECKI risk scores to predict mortality after cardiac rehabilitation among Dutch heart failure patients
por: Kouwert, Ilse JM, et al.
Publicado: (2019)

The Apelin-APJ System in the Evolution of Heart Failure
por: GOIDESCU, CERASELA MIHAELA, et al.
Publicado: (2015)

Depression is the strongest predictor of long-term outcome in patients with chronic nonischemic heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

The Role of Ambulatory Heart Failure Clinics to Avoid Heart Failure Admissions
por: He, Jessica, et al.
Publicado: (2019)

Effect of apelin on the cardiac hemodynamics in hypertensive rats with heart failure
por: PANG, HUI, et al.
Publicado: (2014)

The impact of the coronavirus disease and Tele-Heart Failure Clinic on cardiovascular mortality and heart failure hospitalization in ambulatory patients with heart failure
por: Puwanant, Sarinya, et al.
Publicado: (2021)

Five-year survival of patients with chronic systolic heart failure of ischemic and non-ischemic etiology: analysis of prognostic factors
por: Mościński, Mateusz, et al.
Publicado: (2014)

Differential prognostic accuracy of right ventricular dysfunction, the Seattle heart failure model and the MAGGIC score in patients with severe mitral regurgitation undergoing the MitraClip® procedure
por: Heyl, S., et al.
Publicado: (2020)

Using Atlanta Heart Failure Questionnaire in ambulatory heart failure patients with preserved ejection fraction HFPEF
por: Alghalayini, Kamal W
Publicado: (2020)

Low health-related quality of life is a predictor of major adverse cardiovascular events in patients with chronic nonischemic heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression
por: Atluri, Pavan, et al.
Publicado: (2006)

The Status of Specialized Ambulatory Heart Failure Care in Canada: A Joint Canadian Heart Failure Society and Canadian Cardiovascular Society Heart Failure Guidelines Survey
por: Virani, Sean A., et al.
Publicado: (2020)

Ambulatory haemodynamic‐guided management reduces heart failure hospitalizations in a multicentre European heart failure cohort
por: Dauw, Jeroen, et al.
Publicado: (2022)

Repetitive milrinone therapy in ambulatory advanced heart failure patients
por: Laufer‐Perl, Michal, et al.
Publicado: (2022)

Advanced Heart Failure and End-Stage Heart Failure: Does a Difference Exist
por: Severino, Paolo, et al.
Publicado: (2019)

Ambulatory Heart Failure Monitoring: A Systemic Review
por: Mangi, Muhammad A, et al.
Publicado: (2017)

Ambulatory Resistant Hypertension and Risk of Heart Failure in the Elderly
por: Coccina, Francesca, et al.
Publicado: (2023)

Dilemmas in end-stage heart failure
por: Chen-Scarabelli, Carol, et al.
Publicado: (2015)

Usefulness of the MAGGIC Score in Predicting the Competing Risk of Non-Sudden Death in Heart Failure Patients Receiving an Implantable Cardioverter-Defibrillator: A Sub-Analysis of the OBSERVO-ICD Registry
por: Canepa, Marco, et al.
Publicado: (2021)

Ceruloplasmin as Redox Marker Related to Heart Failure Severity
por: Lazar-Poloczek, Elżbieta, et al.
Publicado: (2021)

Revascularization in ischemic heart failure with reduced left ventricular ejection fraction. The impact of complete revascularization
por: Pyka, Łukasz, et al.
Publicado: (2017)

Targeting the ACE2 and Apelin Pathways Are Novel Therapies for Heart Failure: Opportunities and Challenges
por: Kazemi-Bajestani, Seyyed M. R., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_d0elf69u63afgdclgv27f46ait